NewslettersCell Therapy NewsF77 Antigen Is a Promising Target for Adoptive T Cell Therapy of Prostate CancerBy Jamie Kang - September 18, 20230192Scientists entailed the generation and evaluation of a second-generation CAR against a carbohydrate antigen on malignant prostate cancer cells.[Biochemical And Biophysical Research Communications]Abstract